ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
17.921,95
0,00%
S&P 500
5.018,39
-0,34%
Dow Jones
37.903,29
0,23%
Euro vs US Dollar
1,07185
0,01%
Bitcoin
57.685,17
-0,95%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. PTC Therapeutics Inc (PTCT)

  7. PTC Therapeutics Inc (PTCT) News

PTCT PTC Therapeutics Inc

34,16
0,00 (0,00%)
02 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
PTC Therapeutics Inc PTCT NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,00 0,00% 34,16 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
34,16
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
25.4.202422:05PRNUSPTC Therapeutics Provides Corporate Update and Reports First..
23.4.202422:30PRNUSPTC Therapeutics Reports Inducement Grants Under Nasdaq..
11.4.202414:00PRNUSPTC Therapeutics to Host Conference Call to Discuss First..
28.3.202413:30PRNUSPTC Announces Submission of Sepiapterin MAA for Treatment of..
19.3.202412:30PRNUSPTC Therapeutics Provides Key Regulatory Updates
29.2.202422:05PRNUSPTC Therapeutics Provides Corporate Update and Reports..
27.2.202423:20PRNUSPTC Therapeutics to Participate at Upcoming Investor..
22.2.202422:30PRNUSPTC Therapeutics Reports Inducement Grants Under Nasdaq..
16.2.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202414:00PRNUSPTC Therapeutics to Host Conference Call to Discuss Fourth..
14.2.202421:50EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14.2.202413:13EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01.2.202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.2.202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.2.202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.2.202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.1.202421:30EDGAR2Form 144 - Report of proposed sale of securities
30.1.202421:25EDGAR2Form 144 - Report of proposed sale of securities
30.1.202421:18EDGAR2Form 144 - Report of proposed sale of securities
30.1.202421:18EDGAR2Form 144 - Report of proposed sale of securities
30.1.202421:17EDGAR2Form 144 - Report of proposed sale of securities
25.1.202422:06EDGAR2Form 8-K - Current report
25.1.202422:05PRNUSCHMP Issues Negative Opinion for Renewal of Conditional..
24.1.202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.1.202422:11EDGAR2Form 144 - Report of proposed sale of securities
10.1.202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.1.202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.1.202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.1.202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.1.202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.1.202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.1.202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.1.202423:46EDGAR2Form 144 - Report of proposed sale of securities
09.1.202422:35EDGAR2Form 144 - Report of proposed sale of securities

Kürzlich von Ihnen besucht

NASDAQ
PTCT
PTC Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten